drugset / Trial / NCT00573495
Multipeptide Vaccine for Advanced Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a study on how to activate the immune system with a vaccine. The vaccine is made up of two proteins found in breast cancer: telomerase and survivin. The vaccine is given in combination with other drugs that may also have an effect on the immune system and attack the cancer. The goals of the study are: 1. to test the safety of the combination of agents 2. to find out what effects the treatment has on advanced breast cancer
Timeline
- Start
- 2007-11
- Primary completion
- 2011-07
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hTERT/Survivin Multi-Peptide Vaccine | Vaccine | 100 ug | Subcutaneous |